Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
Portable MRI machine in a hospital room

Jul 28, 2026

New Hyperfine Swoop® Portable MRI for Easier and Faster Stroke Visualization

The Hyperfine Swoop® portable MRI system has been upgraded with AI-supported software, enhancing its capability for stroke visualization.Recently, Lioness Medtech AB announced a significant software update for the Hyperfine Swoop® portable MR Imaging® system, introducing an advanced multi-directional diffusion-weighted imaging (DWI) sequence. This new feature leverages a multi-directional image acquisition method akin to that used in high-field MRI, allowing for faster and clearer visualization
A minimalist representation of DNA and a laboratory flask on a dark background.

Jul 28, 2026

A.P. inks pact with AstraZeneca to set up Genomic Solutions Centre in Amaravati

Andhra Pradesh has officially partnered with AstraZeneca India to create an Integrated Genomic Solutions Centre in Amaravati, a significant advancement in precision cancer care. This initiative aims to establish India's first comprehensive research and treatment ecosystem focused on precision oncology, utilizing cutting-edge genomic technologies for personalized cancer diagnosis and treatment.The Memorandum of Understanding (MoU) was signed in the presence of Chief Minister N. Chandrababu Naidu,
A toilet sensor next to a bowl of water in a dimly lit bathroom.

Jul 28, 2026

Throne Raises $10M to Expand AI Toilet Diagnostics Beyond Gut Health

Throne has successfully secured $10 million in Series A funding to broaden its AI-driven diagnostic capabilities beyond gut health.The funding will enable Throne to enhance its innovative toilet sensor, which utilizes computer vision to analyze bowel movements, providing valuable insights into gut health through an accompanying app. Originally launched in March, the device currently assesses aspects such as consistency and hydration, but the new investment is aimed at advancing features that cou
An eye with a dropper, representing eye drug development.

Jul 28, 2026

An eye drug biotech banks $118M and stocks its executive suite

Claris Biotherapeutics has secured $118 million in funding to advance its experimental eye drug, CSB-001, targeting limbal stem cell deficiency (LSCD). The New Jersey-based biotech has also appointed new leadership to bolster its efforts in this therapeutic area.The Series B funding round was co-led by Samsara BioCapital and Catalio Capital Management, alongside other investors such as Sofinnova Investments and Novo Holdings. Claris aims to initiate late-stage testing for CSB-001 early next year
A military helmet on a conference table with cybersecurity equipment in a dimly lit room.

Jul 28, 2026

US Army Europe and Africa advances AI cyber defence dialogue

The recent summit hosted by US Army Europe and Africa underscores the pivotal role of AI in enhancing military cybersecurity.Gathering over 800 cyber specialists, military leaders, and industry experts from 23 nations, the three-day event from July 21 to 23 focused on AI-driven cybersecurity, critical infrastructure protection, and the future of military cyber operations. Participants explored how current technologies can bolster operational readiness against evolving digital threats, emphasizin
A close-up of a bandaged diabetic foot ulcer on an examination table in a clinical setting.

Jul 28, 2026

AI-powered device to help treat diabetes patients unveiled by medtech firm

A new AI-driven device from Israeli startup TriO aims to significantly mitigate the risk of limb amputations due to diabetic foot ulcers, a severe complication of diabetes.Diabetic foot ulcers are a major concern for individuals with diabetes, often resulting from nerve damage, poor circulation, and elevated blood sugar levels. These ulcers not only pose a high risk of infection but also lead to costly and life-altering complications, including amputations.TriO's innovative device, called Fitt,
Silhouette of a microphone and a person representing leadership in biotechnology

Jul 28, 2026

Legend Biotech and Sarepta CEOs Depart as Patrick Vallance Named UK AI Task Force Chair

The biotechnology sector is experiencing notable leadership changes, with the CEOs of Legend Biotech and Sarepta Therapeutics stepping down, while Patrick Vallance has been appointed to chair the UK's new AI task force.Both Legend Biotech and Sarepta Therapeutics have announced the departures of their chief executives, although they have yet to name successors. This shift in leadership reflects broader transformations within the biotechnology industry, which is currently navigating a rapidly evo
Flat illustration of a tissue sample and research paper in a minimalist style.

Jul 28, 2026

Business Weekly Awards 2026: 44 shortlisted companies revealed for Cambridge Tech and Life Sciences showcase

The Business Weekly Awards 2026 has unveiled its shortlist, highlighting 44 innovative companies in the Cambridge tech and life sciences sectors, showcasing the region's robust ecosystem.The shortlist underscores the dynamic nature of the Cambridge Cluster, particularly its life sciences and technology companies. Many of these contenders have emerged from academic settings, reflecting the area's strong emphasis on research and innovation. Among the notable technology firms are 1956 Individuals,
A minimalist illustration of gears representing collaboration in AI.

Jul 28, 2026

Initech builds AI alliance with AIworks and Hypernology to target enterprise AX

Initech has partnered with AIworks and Hypernology to form an alliance focused on integrating various AI technologies into enterprise applications.On July 28, Initech, AIworks, and Hypernology announced a collaborative agreement to create an "AI alliance" that merges their strengths in industrial artificial intelligence, generative AI, and financial information technology. This partnership aims to identify new business opportunities across sectors such as manufacturing, finance, and public servi
A blood sample in a vial on a lab bench with a syringe.

Jul 28, 2026

Blood Testing Market to Surpass US$ 249.7 Billion by 2035, Fueled

The global blood testing market is projected to exceed $249.7 billion by 2035, driven by advancements in technology and an increasing burden of chronic diseases.The blood testing sector is experiencing significant growth, largely due to healthcare providers' reliance on blood diagnostics for disease detection and monitoring. As a crucial tool for evaluating health, blood tests facilitate early diagnosis and timely medical interventions, enhancing patient outcomes. The market, valued at approxima
An upward trend arrow representing rising healthcare stocks

Jul 28, 2026

Healthcare stocks climb as Gilead, Regeneron and Bristol Myers lead gains across pharma sector

Healthcare stocks experienced a notable uptick, driven by significant gains from key players like Gilead Sciences, Regeneron Pharmaceuticals, and Bristol Myers Squibb.During a recent trading session, the healthcare sector saw a positive shift, with Gilead Sciences rising by 2.88%, closely followed by Regeneron Pharmaceuticals at 2.89%. Bristol Myers Squibb also contributed to the rally with a 2.11% increase. Other major companies, including Zoetis, Johnson & Johnson, Pfizer, Merck, and AbbVie, a
A flat illustration of a proxy drug molecule interacting with a target protein in a laboratory setting.

Jul 28, 2026

Insights from SLAS Europe 2026 - SelectScience interview

At the Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), researchers are pioneering the integration of academic research and industrial applications in drug discovery. Their focus is on developing proximity-inducing drugs, which differ from traditional small molecules by modulating protein interactions rather than merely inhibiting protein functions.Proximity-inducing drugs, or proxy drugs, operate by binding to a target protein and recruiting another protein via mechanism